Smith & Nephew Share Discussion Threads

[broadwood] 30/10/2014 15:51

Medical devices maker Smith & Nephew posted a 3% increase in both revenue and profit for the third quarter, thanks to an improvement in its emerging and international markets units, recent product launches and investment in the sales force.
On an underlying basis, turnover climbed from $1,027m to $1,148m, thanks to its Sports Medicine and Trauma & Extremities divisions, which benefitted from recent product launches and investment in the US sales force.

The group reported success with its expansion plans for sports medicine, with the division seeing 11% revenue growth as it gained from the success of a number of recent product launches.

Its other main area of expansion, wound-care markets, was as expected held back by US Negative Pressure Wound Therapy. The division reported a 3% decline in revenue, although this was still an improvement on the second quarter.

The Advanced Surgical Devices division posted a 4% increase in revenue to $816m, thanks to growth across its Arthroscopic Enabling Technologies, Hip and Knee Implants and its overall performance in the US and Emerging & International Markets.

The latter continued to deliver strong growth, with revenue up 20% in the quarter, including an improving contribution from its distributor acquisitions in Brazil.

Group trading profit climbed from $222m to $246m, marking a gain of 3%, although on a reported basis it rose 10%. The trading profit margin was 21.4%, compared to 21.6% in the same period a year earlier.

Chief executive officer Olivier Bohuon said: "We are delivering on our strategy to rebalance Smith & Nephew by strengthening our higher growth platforms, which currently represent more than half the business, up from just 35% three years ago.

"Sports Medicine Joint Repair and Advanced Wound Bioactives both produced double-digit growth in the quarter, and the emerging markets business increased revenue by 20%. We are pleased with our momentum, enhanced by group optimisation, tax improvement and the acquisition of ArthroCare. Adjusted earnings per share grew 14% in the quarter.

"The quarter positively reflects our strategy to rebalance towards higher growth markets, and we have many actions underway to further build upon these achievements."

For the nine-month period, reported revenues were $3,368m, up 2% on an underlying basis year-on-year. Trading profit was $730m, against $695m a year earlier, although the trading profit margin slipped from 21.9% to 21.7%.

[knighty0001] 13/10/2014 09:21

So the CEO announces the clinical trial failure. On top of the FDA issues with NPWT. The wound management division will be taking a huge hit end of this year and best part of next year I expect.

[scrapman] 14/8/2014 12:17

very steady volumes for the last week , wish JnJ would get a move on :-))

[tiptv1] 11/8/2014 14:50

Zak Mir offers his Major Market Round-up and Market Discussion of the FTSE 100 and says Smith & Nephew (SN.) Buy and Hold - See more at:

[steeplejack] 06/8/2014 12:07

Three democrats asking Obama to close inversion tax plays.Hence ,Shire down followed by AstraZeneca and Smith and Nephew.

[leeson31] 04/8/2014 08:03

something going on :-)

[leeson31] 01/8/2014 08:23

seems to be finding support at the ~1020p area..

[broadwood] 01/8/2014 08:20

Now, where's that takeover bid?

[tiptv1] 29/7/2014 12:35

Zak Mir live Charting on TipTV offering a technical view on Smith & Nephew PLC (SN.L) - See more at:

[scrapman] 17/7/2014 19:20

16 days , no comments ,

bit of a lift today , after JNJ's profits would be nice for them to do the decent thing

[tiptv1] 11/7/2014 14:00

TipTV's Zak Mir says to BUY in Smith & Nephews PLC (SN.L). Watch here:

[arja] 01/7/2014 21:41

turning up in USA and should follow suit in Uk - pullback over I suspect !

[scrapman] 24/6/2014 11:07

looks like a retrace is on the cards , could be a good short , back to the £9 ,,£9-50 range

[arja] 23/6/2014 19:59

lacklustre lately and I am sorry I still hold them. Might be more t/o talk soon I hope !

[scrapman] 23/6/2014 12:16

seems like lowish volumes today , perhaps it's time for some form of announcement on who has been picking these up ,

could do with a bit of decent news in these markets for a change.

couple of comments about the recent US interest in European Pharma companies fwiw

hxxp://www.bidnessetc.com/22203-shire-refuses-abbvies-acquisition-bid-is-a-better-deal-in-the-making/

[scrapman] 20/6/2014 09:28

bit chipper this morning ,going for this weeks big turnover day ?

[arja] 20/6/2014 08:20

up in sympathy with SHP today ?

[scrapman] 19/6/2014 12:58

round up of comments from Telegraph fwiw

[scrapman] 18/6/2014 16:29

strange trade there at 16.23 , 300k through in two hits at 10.63 , bid offer 10.53/54 , convinced someone is hoovering chunks of these at vwap

[edwardt] 16/6/2014 15:40

jnj it is then...

[scrapman] 16/6/2014 12:53

very surprised at todays reaction to the MDT news ,thought there would have been a rush for the door , seems like the buyers still there for now

[scrapman] 16/6/2014 10:33

don't know f this any use to you Leeson,

[leeson31] 16/6/2014 09:04

ok, cheers Arja!